ASC4KIDS: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Chronic Myeloid Leukemia in the Chronic Phase

Hijiya, N., Kapoor, S., Hoch, M., Descamps, L., Dhamal, V., & Torres Cardoso, A. P. (2023). ASC4KIDS: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Chronic Myeloid Leukemia in the Chronic Phase. Blood, 142(Supplement 1), 6387–6387. https://doi.org/10.1182/blood-2023-185535
Authors:
Nobuko Hijiya
S. S. Kapoor
Matthias Hoch
Laurence Descamps
Vishal Dhamal
Ana Paula Torres Cardoso
Affiliated Authors:
Nobuko Hijiya
Columbia Affiliation:
Subjects:
Efficacy and Resistance in CML Treatment (OpenAlex Topic)
Evolution and Management of Fungicide Resistance in Plant Pathogens (OpenAlex Topic)
Chemistry and Pharmacology of Quinazoline Compounds (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2023-185535
DOI:
10.1182/blood-2023-185535
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: